Kingsview Wealth Management LLC cut its stake in The Allstate Co. (NYSE:ALL - Free Report) by 87.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,682 shares of the insurance provider's stock after selling 33,581 shares during the period. Kingsview Wealth Management LLC's holdings in Allstate were worth $888,000 as of its most recent SEC filing.
A number of other institutional investors have also recently bought and sold shares of ALL. Northwest Investment Counselors LLC purchased a new stake in shares of Allstate during the 3rd quarter valued at $28,000. Catalyst Capital Advisors LLC purchased a new stake in Allstate during the third quarter valued at about $29,000. Versant Capital Management Inc grew its position in Allstate by 70.9% during the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider's stock valued at $30,000 after acquiring an additional 78 shares during the period. Family Firm Inc. acquired a new stake in Allstate during the second quarter worth about $38,000. Finally, MCF Advisors LLC raised its holdings in shares of Allstate by 33.9% in the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider's stock worth $53,000 after purchasing an additional 84 shares during the period. 76.47% of the stock is currently owned by hedge funds and other institutional investors.
ALL opened at $207.80 on Wednesday. The company has a market capitalization of $55.03 billion, a P/E ratio of 13.46, a PEG ratio of 1.81 and a beta of 0.48. The company has a 50-day moving average of $191.99 and a 200-day moving average of $178.36. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The Allstate Co. has a 1-year low of $134.17 and a 1-year high of $208.23.
Allstate (NYSE:ALL - Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, beating the consensus estimate of $2.20 by $1.71. The firm had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. Allstate had a return on equity of 26.67% and a net margin of 6.77%. Allstate's quarterly revenue was up 14.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.81 earnings per share. Equities analysts expect that The Allstate Co. will post 16.07 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th will be issued a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 1.77%. The ex-dividend date of this dividend is Friday, November 29th. Allstate's dividend payout ratio is presently 23.83%.
In other news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares of the company's stock, valued at approximately $5,236,922.32. The trade was a 57.06 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 1.80% of the stock is owned by insiders.
A number of analysts recently issued reports on the stock. Wells Fargo & Company increased their target price on shares of Allstate from $175.00 to $186.00 and gave the stock an "equal weight" rating in a research report on Tuesday, November 5th. Jefferies Financial Group increased their price objective on shares of Allstate from $231.00 to $267.00 and gave the stock a "buy" rating in a research report on Friday, November 8th. Roth Mkm restated a "buy" rating and set a $200.00 target price on shares of Allstate in a report on Wednesday, August 14th. JPMorgan Chase & Co. increased their price target on Allstate from $205.00 to $207.00 and gave the company an "overweight" rating in a report on Thursday, October 10th. Finally, Keefe, Bruyette & Woods boosted their price objective on Allstate from $222.00 to $225.00 and gave the stock an "outperform" rating in a research note on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Allstate has an average rating of "Moderate Buy" and an average target price of $217.19.
Get Our Latest Stock Analysis on Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.